|
Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Clinical research trials and Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL). Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL) condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)  Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
For Condition: Leukemia, Lymphocytic, Chronic
Status: Recruiting
Sponsor(s): Ligand Pharmaceuticals ,
Synopsis: The purpose of this study is to evaluate the safety and effectiveness of ONTAK in previously treated patients with chronic lymphocytic leukemia (CLL)
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Patients with B-cell Chronic Lymphocytic Leukemia, Rai Stage 0-II with indication for treatment by NCI Working Group Criteria or Rai Stage III or IV. - Patients must have received at least one prior purine analogue-based chemotherapy regimen. - ECOG Performance Status of 0, 1, or 2. - Patients must not have had previous treatment with ONTAK. - Female patients cannot be pregnant and must use birth control during the course of the study and for three weeks after the study ends. - Patients must not receive therapy for CLL within 35 days prior to study.
Total Enrollment: 41
Location and Contact Information:
Overall Study Official:
GordonBray, Study Director, Ligand Pharmaceuticals
Peter MacCallum Cancer Institute *Recruiting*
East Melbourne, Victoria, 3002
Australia
Recruiting
Rush-Presbyterian St. Luke's Cancer Center *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting
UCSD School of Medicine *Recruiting*
La Jolla, California, 92093-0663
United States
Recruiting
University of Texas, M.D. Anderson Cancer Center *Recruiting*
Houston, Texas,
United States
Recruiting
Additional Information:
Study ID Numbers: L4389-34;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00055146
Other Leukemia, Lymphocytic, Chronic Studies:
1. Chemotherapy Related Anemia in Patients with Non-Myeloid Malignancies
2. Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
3. A Pilot Study of Pivanex in Patients with Chronic Lymphocytic Leukemia
4. Chemotherapy Related Anemia
5. A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach
Related Studies:
Other Leukemia, Lymphocytic, Chronic Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
Study of ONTAK in patients with B-Cell Chronic Lymphocytic Leukemia (CLL)
|
|
|
|
|
|
|
|
